Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline forms of salts of fused penta-cyclic dihydrodiazepinocarbazolones, and uses thereof

Crystalline forms of salts of fused penta-cyclic dihydrodiazepinocarbazolones, and uses thereof

US Patent 10899763 · Granted Jan 26, 2021

Estimated economic value: $204,177,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist2025
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer2022
Benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenases2022
Benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenases2022
Pyrazolotriazolopyrimidine derivatives as A2A receptor antagonist2022
Treatment cancers using a combination comprising PARP inhibitors2021
Treatment cancers using a combination comprising PARP inhibitors2021
5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleam2021
5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleam2021
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer2020
5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,32020
5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,32020